BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36290901)

  • 1. Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform.
    Banyi N; Alex D; Hughesman C; McNeil K; N Ionescu D; Ma C; Yip S; Melosky B
    Curr Oncol; 2022 Oct; 29(10):7900-7911. PubMed ID: 36290901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S; Satapathy A; Aggarwal A; Dewan A; Jain E; Katara R; Kumar V; Pal R; Pandey S; Naidu MM; Kini L; Pradhan D; Mohanty SK
    Pathol Res Pract; 2021 Apr; 220():153394. PubMed ID: 33706124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla
    Michaelidou K; Karniadakis I; Pantelaion V; Koutoulaki C; Boukla E; Folinas K; Dimaras P; Papadaki MA; Koutsopoulos AV; Mavroudis D; Vourlakou C; Mavridis K; Agelaki S
    Expert Rev Mol Diagn; 2024; 24(1-2):89-98. PubMed ID: 38193169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idylla
    Khalifa E; Chapusot C; Tournier B; Sentis J; Marion E; Remond A; Aubry M; Pioche C; Bergeron A; Primois C; Blanchard L; Millière A; Boucheix M; Léger Y; Bairrao M; Brouste V; Martin L; Soubeyran I
    J Clin Pathol; 2023 Oct; 76(10):698-704. PubMed ID: 35820776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the Idylla
    Petiteau C; Robinet-Zimmermann G; Riot A; Dorbeau M; Richard N; Blanc-Fournier C; Bibeau F; Deshayes S; Bergot E; Gervais R; Levallet G
    Curr Oncol; 2021 Nov; 28(6):4432-4445. PubMed ID: 34898548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma.
    Colling R; Bancroft H; Langman G; Soilleux E
    Virchows Arch; 2019 Feb; 474(2):187-192. PubMed ID: 30470932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
    De Luca C; Rappa AG; Gragnano G; Malapelle U; Troncone G; Barberis M
    J Clin Pathol; 2018 Aug; 71(8):745-750. PubMed ID: 29798838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
    Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M
    J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced sensitivity for
    Lee E; Jones V; Topkas E; Harraway J
    J Clin Pathol; 2021 Jan; 74(1):43-47. PubMed ID: 32467321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC.
    Behnke A; Cayre A; De Maglio G; Giannini G; Habran L; Tarsitano M; Chetta M; Cappellen D; Lespagnol A; Le Naoures C; Massazza G; Destro A; Bonzheim I; Rau A; Battmann A; Kah B; Watkin E; Hummel M
    Pathol Oncol Res; 2023; 29():1610707. PubMed ID: 36798672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
    Delgado-García M; Weynand B; Gómez-Izquierdo L; Hernández MJ; Blanco ÁM; Varela M; Matias-Guiu X; Nadal E; Márquez-Lobo B; Alarcão A; de Álava E; Biscuola M
    BMC Cancer; 2020 Apr; 20(1):275. PubMed ID: 32245434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of rapid PCR testing as an adjunct to NGS in diagnostic pathology services within the UK: evidence from a case series of non-squamous, non-small cell lung cancer (NSCLC) patients with follow-up.
    Finall A; Davies G; Jones T; Emlyn G; Huey P; Mullard A
    J Clin Pathol; 2023 Jun; 76(6):391-399. PubMed ID: 35042754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
    Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
    Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies].
    Chevalier LM; Billaud A; Passot C; Renoult A; Bigot F; Verrièle V; Morel A
    Ann Pathol; 2020 Sep; 40(5):389-400. PubMed ID: 32081549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a fast and fully automated platform to diagnose
    Lambros L; Caumont C; Guibourg B; Barel F; Quintin-Roué I; Marcorelles P; Merlio JP; Uguen A
    J Clin Pathol; 2017 Jun; 70(6):544-549. PubMed ID: 28153953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed, paraffin-embedded tissue of human lung cancer.
    Xu Y; Zhang L; Jia L; Ren M; Xue T; Bai Q; Yao Q; Wei R; Zhou X; Zhu X
    J Thorac Dis; 2024 Jan; 16(1):40-50. PubMed ID: 38410581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review.
    Caputo A; D'Ardia A; Sabbatino F; Picariello C; Ciaparrone C; Zeppa P; D'Antonio A
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR Mutation Analysis in Non-small Cell Lung Carcinoma from Tissue Samples Using the Fully Automated Idylla™ qPCR System.
    Heeke S; Hofman P
    Methods Mol Biol; 2019; 2054():147-155. PubMed ID: 31482454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid clinical mutational testing of
    Van Haele M; Vander Borght S; Ceulemans A; Wieërs M; Metsu S; Sagaert X; Weynand B
    J Clin Pathol; 2020 Jan; 73(1):35-41. PubMed ID: 31296605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Ultra-Rapid Idylla™ EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular Screening.
    Suda K; Sakai K; Ohira T; Chikugo T; Satou T; Matsubayashi J; Nagao T; Ikeda N; Tsutani Y; Mitsudomi T; Nishio K
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.